Delia D'avola
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Role of activity and fibrosis in the MASLD atherogenic momentum through advanced lipidomics.
Journal: PloS one
Published: October 16, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?
Journal: Cancers
Published: July 14, 2025
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment.
Journal: Clinical and molecular hepatology
Published: October 24, 2023
Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment.
Journal: Journal of physiology and biochemistry
Published: November 24, 2022
Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events.
Journal: Journal of clinical medicine
Published: July 05, 2022
Pathophysiology of attacks in acute hepatic porphyrias
Journal: Medicina clinica
Published: February 09, 2022
Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood.
Journal: Bioengineering & translational medicine
Published: October 06, 2021
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone-Dependent Release of Circulating Tumor DNA.
Journal: Hepatology communications
Published: November 05, 2020
The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma.
Journal: Journal of hepatology
Published: September 08, 2020
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.
Journal: PLoS genetics
Published: July 02, 2020
Last Updated: 09/26/2026